NASDAQ: CDTRank 07 / 10Biopharma asset platform
CDT Equity Inc.
Formerly Conduit Pharmaceuticals. Identifies, enhances and repositions therapeutic assets using AI and solid-form chemistry, monetised through licensing and M&A.
cdtequity.com ↗0.0670USD-4.29%
Market cap$624.6K
Shares (impl.)9,322,806
52W high17,750
52W low0.0540
From high-99.9996%
Volume4,304,200
Why it is on the list
Management has said, in its own description, that strategic M&A is the plan. A company already open to transactions is the shortest path from position to influence.
Principal risk
Sub-$0.10 share price puts Nasdaq minimum-bid compliance in question; reverse split probable.
A
Ownership ladder
Costs at last print, before price impact
Routed to CDT
…
—
Fundable stake
0%
of shares outstanding
Paired tokens
…
1%
5%
10%
50.1%
0.001%0.01%0.1%1%10%100%
Share of company fundable by routed fees · log scale
| Stake | Meaning | Cost | To go |
|---|---|---|---|
| 1% | Top-holder list on most micro-caps | $6.2K | $6.2K |
| 5% | Schedule 13D/13G beneficial-owner filing | $31.2K | $31.2K |
| 10% | Section 16 insider status | $62.5K | $62.5K |
| 50.1% | Majority control of the vote | $312.9K | $312.9K |
Reading pools…